标题
Oxidation pathway and exacerbations in COPD: the role of NAC
作者
关键词
-
出版物
Expert Review of Respiratory Medicine
Volume 10, Issue 1, Pages 89-97
出版商
Informa UK Limited
发表日期
2015-11-16
DOI
10.1586/17476348.2016.1121105
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prevention of Acute Exacerbations of COPD
- (2015) Gerard J. Criner et al. CHEST
- Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives
- (2015) Mario Cazzola et al. DRUGS
- Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy
- (2015) Luigino Calzetta et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- COPD: balancing oxidants and antioxidants
- (2015) Bernard Fischer et al. International Journal of Chronic Obstructive Pulmonary Disease
- Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes
- (2015) Jianqing Zhang et al. International Journal of Chronic Obstructive Pulmonary Disease
- Benefits of High-Dose N-Acetylcysteine to Exacerbation-Prone Patients With COPD
- (2014) Hoi Nam Tse et al. CHEST
- Oxidative Stress and Respiratory System: Pharmacological and Clinical Reappraisal of N-Acetylcysteine
- (2014) Pierachille Santus et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Defining Phenotypes in COPD: An Aid to Personalized Healthcare
- (2014) Andrea Segreti et al. Molecular Diagnosis & Therapy
- Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease
- (2014) Hoi Nam Tse et al. International Journal of Chronic Obstructive Pulmonary Disease
- Oxidative stress and free radicals in COPD – implications and relevance for treatment
- (2014) Wolfgang Domej et al. International Journal of Chronic Obstructive Pulmonary Disease
- Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial
- (2014) Jin-Ping Zheng et al. Lancet Respiratory Medicine
- N-acetylcysteine in COPD may be beneficial, but for whom?
- (2014) Mario Cazzola et al. Lancet Respiratory Medicine
- High-Dose N-Acetylcysteine in Stable COPD
- (2013) Hoi Nam Tse et al. CHEST
- Oxidative Stress in COPD
- (2013) Paul A. Kirkham et al. CHEST
- Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits
- (2013) Gordon F. Rushworth et al. PHARMACOLOGY & THERAPEUTICS
- Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study
- (2013) Ravikumar Sinojia et al. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
- Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients
- (2013) Jan De Backer et al. International Journal of Chronic Obstructive Pulmonary Disease
- Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
- (2013) Jadwiga A Wedzicha et al. Lancet Respiratory Medicine
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
- (2012) Jørgen Vestbo et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- Antioxidant pharmacological therapies for COPD
- (2012) Irfan Rahman et al. CURRENT OPINION IN PHARMACOLOGY
- N-acetyl-l-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)
- (2011) Manuel Mata et al. BIOCHEMICAL PHARMACOLOGY
- The short, the long and the “ultra-long”: Why duration of bronchodilator action matters in chronic obstructive pulmonary disease
- (2010) Kai M. Beeh et al. ADVANCES IN THERAPY
- N-acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus
- (2009) Janina Geiler et al. BIOCHEMICAL PHARMACOLOGY
- Effect of N-Acetylcysteine on Air Trapping in COPD
- (2009) David Stav et al. CHEST
- Inhaled muscarinic antagonists for COPD—does an anti-inflammatory mechanism really play a role?
- (2009) Michael Trevethick et al. CURRENT OPINION IN PHARMACOLOGY
- Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype
- (2009) Ji-Hyun Lee et al. RESPIRATORY MEDICINE
- Outcomes for COPD pharmacological trials: from lung function to biomarkers
- (2008) M. Cazzola et al. EUROPEAN RESPIRATORY JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started